Antibiotic Resistance in Helicobacter pylori Strains and its Effect on H-pylori Eradication Rates in a Single Center in Korea

被引:51
作者
An, Byoungrak [1 ]
Moon, Byung Soo [2 ]
Kim, Heejung [3 ]
Lim, Hyun Chul [2 ]
Lee, Yong Chan [2 ]
Lee, Gyusang [4 ]
Kim, Sa-Hyun [4 ]
Park, Min [4 ]
Kim, Jong Bae [4 ]
机构
[1] Yongin Severance Hosp, Dept Lab Med, Yongin, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[4] Yonsei Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Wonju 220710, South Korea
关键词
Helicobacter pylori; Antibiotic resistance; Eradication; ANTIMICROBIAL RESISTANCE; INFECTION; CLARITHROMYCIN;
D O I
10.3343/alm.2013.33.6.415
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: Clarithromycin, amoxicillin, metronidazole, tetracycline, and levofloxacin have been commonly used for the eradication of Helicobacter pylori. We compared the change in antibiotic resistance of H. pylori strains during two separate periods and investigated the effect of antibiotic resistance on H. pylori eradication. Methods: H. pylori strains were isolated from 71 patients between 2009 and 2010 and from 94 patients between 2011 and 2012. The distribution of minimal inhibitory concentration (MIC) of 5 antibiotics was assessed using the agar dilution method, and H. pylori eradication based on the antimicrobial susceptibility of the isolates was investigated retrospectively. Results: Antibiotic resistance rate against clarithromycin, amoxicillin, tetracycline, metronidazole, and levofloxacin for the 2009-2010 isolates were 7.0% (5/71), 2.8% (2/71), 0% (0/71), 45.1% (32/71), and 26.8% (19/71), respectively, and for the 2011-2012 isolates were 16.0% (15/94), 2.1% (2/94), 0% (0/94), 56.3% (53/94), and 22.3% (21/94), respectively. Multi-drug resistance for 2 or more antibiotics increased slightly from 16.9% (12/71) in the 2009-2010 isolates to 23.4% (22/94) in the 2011-2012 isolates. In follow-up testing of 66 patients, first-line treatment successfully eradicated H. pylori in 50 patients (75.8%) and failed in 4 of 7 patients (57.1%) in a clarithromycin-resistant and amoxicillin-susceptible group. Conclusions: We observed an increase in resistance to clarithromycin and an overall increase in multi-drug resistance during the 2 study periods. The effectiveness of the eradication regimen was low with combinations of clarithromycin and amoxicillin, particularly in the clarithromycin-resistant group. Thus, eradication of H. pylori depends upon periodic monitoring of antimicrobial susceptibility.
引用
收藏
页码:415 / 419
页数:5
相关论文
共 19 条
[1]
Choi You Sik, 2006, Korean J Gastroenterol, V48, P156
[2]
Clinical and Laboratory Standards Institute, 2008, M2A9 CLIN LAB STAN S
[3]
Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases [J].
Eun, CS ;
Han, DS ;
Park, JY ;
Jeon, YC ;
Hahm, JS ;
Kim, KS ;
Kang, JO .
JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) :436-441
[4]
European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori [J].
Glupczynski, Y ;
Mégraud, F ;
Lopez-Brea, M ;
Andersen, LP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (11) :820-823
[5]
Change in Antibiotic Resistance of Helicobacter pylori Strains and the Effect of A2143G Point Mutation of 23S rRNA on the Eradication of H-pylori in a Single Center of Korea [J].
Hwang, Tae Jun ;
Kim, Nayoung ;
Kim, Hong Bin ;
Lee, Byoung Hwan ;
Nam, Ryoung Hee ;
Park, Ji Hyun ;
Lee, Mi Kyoung ;
Park, Young Soo ;
Lee, Dong Ho ;
Jung, Hyun Chae ;
Song, In Sung .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (08) :536-543
[6]
Kim Jae Yeon, 2011, Korean J Gastroenterol, V57, P221, DOI 10.4166/2011.57.4.221
[7]
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea [J].
Kim, JJ ;
Reddy, R ;
Lee, M ;
Kim, JG ;
El-Zaatari, FAK ;
Osato, MS ;
Graham, DY ;
Kwon, DH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) :459-461
[8]
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients [J].
Kim, JM ;
Kim, JS ;
Kim, N ;
Jung, HC ;
Song, IS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) :965-967
[9]
Kim JM, 2004, KOREAN J GASTROENTER, V44, P126
[10]
Kim MH, 2012, KOREAN J HELICOBACTE, V12, P82